HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
 Help
ADPT [NASD]
Adaptive Biotechnologies Corporation
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-1.63 Insider Own2.20% Shs Outstand141.70M Perf Week6.61%
Market Cap1.08B Forward P/E- EPS next Y-1.64 Insider Trans-3.19% Shs Float139.87M Perf Month-4.08%
Income-229.40M PEG- EPS next Q-0.43 Inst Own86.60% Short Float4.94% Perf Quarter-43.04%
Sales154.50M P/S6.97 EPS this Y-32.50% Inst Trans1.95% Short Ratio4.95 Perf Half Y-70.77%
Book/sh3.90 P/B2.11 EPS next Y1.20% ROA-24.10% Target Price17.25 Perf Year-78.26%
Cash/sh2.78 P/C2.96 EPS next 5Y8.30% ROE-36.70% 52W Range6.20 - 43.40 Perf YTD-70.71%
Dividend- P/FCF- EPS past 5Y- ROI-34.60% 52W High-81.06% Beta-
Dividend %- Quick Ratio3.50 Sales past 5Y- Gross Margin66.00% 52W Low32.58% ATR0.70
Employees858 Current Ratio3.60 Sales Q/Q0.50% Oper. Margin- RSI (14)46.85 Volatility6.40% 9.36%
OptionableYes Debt/Eq0.00 EPS Q/Q-51.40% Profit Margin- Rel Volume0.83 Prev Close7.57
ShortableYes LT Debt/Eq0.00 EarningsMay 04 AMC Payout- Avg Volume1.40M Price8.22
Recom1.90 SMA204.02% SMA50-20.36% SMA200-63.87% Volume1,153,171 Change8.59%
Feb-16-22Reiterated JP Morgan Overweight $75 → $50
Feb-16-22Reiterated Goldman Neutral $54 → $21
Feb-16-22Reiterated BTIG Research Buy $35 → $30
Feb-16-22Reiterated BofA Securities Buy $40 → $32
Oct-15-21Resumed Cowen Outperform
Mar-03-21Downgrade Goldman Buy → Neutral $74 → $63
Oct-08-20Resumed BTIG Research Buy $60
Sep-09-20Initiated Morgan Stanley Equal-Weight $42
Jun-03-20Initiated Goldman Buy $60
Jul-23-19Initiated BTIG Research Buy $46
Jul-22-19Initiated William Blair Outperform
Jul-22-19Initiated Guggenheim Buy $47
Jul-22-19Initiated Goldman Neutral $32
Jul-22-19Initiated Cowen Outperform
Jul-22-19Initiated BofA/Merrill Buy $45
May-26-22 08:00AM  
Adaptive Biotechnologies to Participate in Upcoming June Investor Conferences
GlobeNewswire
May-13-22 10:35AM  
10 Amazing Stocks Under $10 (Part II)
Motley Fool +19.77%
May-04-22 10:30PM  
Adaptive Biotechnologies Corporation (ADPT) Q1 2022 Earnings Call Transcript
Motley Fool
06:35PM  
Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Lags Revenue Estimates
Zacks
04:05PM  
Adaptive Biotechnologies Reports First Quarter 2022 Financial Results
GlobeNewswire
09:59AM  
Is Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Trading At A 50% Discount?
Simply Wall St.
May-02-22 04:05PM  
Adaptive Biotechnologies to Present at the BofA Securities 2022 Healthcare Conference
GlobeNewswire
Apr-05-22 04:30PM  
Adaptive Biotechnologies to Report First Quarter Financial Results on May 4, 2022
GlobeNewswire -6.74%
Mar-31-22 11:16AM  
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Motley Fool
05:46AM  
Cathie Wood Can't Get Enough of These 2 Biotech Stocks
Motley Fool
Mar-25-22 04:54PM  
How Many Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Shares Do Institutions Own?
Simply Wall St.
01:24PM  
Cathie Wood Buys Into a Biotech With a Covid Connection
TheStreet.com
Mar-22-22 10:10AM  
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Motley Fool +5.38%
Mar-11-22 12:43PM  
10 Stock Picks of Julian Robertsons Tiger Management
Insider Monkey -8.41%
Mar-10-22 10:15AM  
Adaptive Biotechnologies (ADPT) Rises on Restructuring Plans
Zacks -6.32%
Mar-09-22 10:37AM  
Adaptive Biotechnologies To Lay Off ~12% Of Its Workforce, Names Tycho Peterson As CFO
Benzinga +9.57%
07:00AM  
Adaptive Biotechnologies Appoints Tycho Peterson as Chief Financial Officer, Reorganizes and Streamlines Workforce to Drive Growth in Two Key Business Areas
GlobeNewswire
01:34AM  
Adaptive Biotechnologies laying off 100 employees in organizational shakeup
American City Business Journals
Mar-02-22 04:05PM  
Adaptive Biotechnologies to Present at the 42nd Annual Cowen Healthcare Conference
GlobeNewswire -6.04%
Feb-22-22 11:21AM  
9 Stocks to Buy According to Billionaire Andreas Halvorsens Viking Global
Insider Monkey
Feb-18-22 11:35AM  
Adaptive Biotechnologies Announces New Data Demonstrating ImmunoSEQ® Technology Can Identify T-Cell Receptors Associated with Crohns Disease
GlobeNewswire -5.46%
09:21AM  
Viking Globals Top 10 Stocks
Insider Monkey
Feb-15-22 07:30PM  
Adaptive Biotechnologies Corporation (ADPT) Q4 2021 Earnings Call Transcript
Motley Fool
05:55PM  
Adaptive Biotechnologies (ADPT) Reports Q4 Loss, Tops Revenue Estimates
Zacks
04:09PM  
Billionaire Richard Chilton is Dumping These 10 Stocks
Insider Monkey
04:05PM  
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire
Feb-08-22 03:00PM  
Analysts Estimate Adaptive Biotechnologies (ADPT) to Report a Decline in Earnings: What to Look Out for
Zacks
04:26AM  
We're Not Very Worried About Adaptive Biotechnologies' (NASDAQ:ADPT) Cash Burn Rate
Simply Wall St.
Feb-02-22 04:05PM  
Adaptive Biotechnologies to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
GlobeNewswire -5.79%
Jan-31-22 01:12PM  
10 Stocks to Sell According to Billionaire Richard Chilton
Insider Monkey +15.96%
10:00AM  
After Plunging 46.4% in 4 Weeks, Here's Why the Trend Might Reverse for Adaptive Biotechnologies (ADPT)
Zacks
Jan-25-22 05:38PM  
Stanley-Laman Group, Ltd. Buys Robinhood Markets Inc, SiTime Corp, Snap Inc, Sells NVIDIA Corp, ...
GuruFocus.com
10:00AM  
Bears are Losing Control Over Adaptive Biotechnologies (ADPT), Here's Why It's a 'Buy' Now
Zacks
Jan-24-22 04:05PM  
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2021 Financial Results on February 15, 2022
GlobeNewswire
01:38PM  
DDD Partners, LLC Buys Intel Corp, Novo Nordisk A/S, Broadcom Inc, Sells Adaptive ...
GuruFocus.com
Jan-20-22 10:39AM  
Gamida (GMDA) Up on Omidubicel BLA Rolling Submission Plan
Zacks
Jan-12-22 10:42AM  
Vertex (VRTX) Kaftrio Gets Europe Nod for CF in Children
Zacks -5.20%
Jan-10-22 08:30AM  
Adaptive Biotechnologies Announces Preliminary, Unaudited 2021 Revenue Results and CFO Transition
GlobeNewswire -5.27%
Jan-04-22 04:05PM  
Updated: Adaptive Biotechnologies to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
GlobeNewswire -8.51%
Jan-03-22 07:00PM  
3 COVID Stocks That Could Double in 2022
Motley Fool
Dec-29-21 08:00AM  
Adaptive Biotechnologies to Present Virtually at the 40th Annual J.P. Morgan Healthcare Conference
GlobeNewswire
Dec-22-21 11:11AM  
Biotech: Interest in vaccine stocks will probably wane, strategist says
Yahoo Finance Video
Dec-13-21 04:05PM  
Adaptive Biotechnologies Announces New Data Demonstrating the Benefit of Serial MRD Testing with the clonoSEQ® Assay in Patients with Blood Cancers at the 63rd ASH Annual Meeting
GlobeNewswire
Dec-12-21 10:41PM  
Do Hedge Funds Love Adaptive Biotechnologies Corporation (ADPT)?
Insider Monkey
Dec-10-21 04:33AM  
Strong week for Adaptive Biotechnologies (NASDAQ:ADPT) shareholders doesn't alleviate pain of one-year loss
Simply Wall St.
Dec-02-21 08:00AM  
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts on Utility of clonoSEQ® in MRD Testing in Blood Cancer Patients at the 63rd ASH Annual Meeting
GlobeNewswire
Nov-29-21 06:44AM  
Cathie Wood Goes Bargain Shopping -- 3 Troubled Stocks She Just Bought
Motley Fool -5.23%
Nov-25-21 05:57AM  
3 Biotech Stocks That Can Double Your Money, According to Wall Street
Motley Fool
Nov-12-21 07:40AM  
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
Benzinga
Nov-11-21 05:52PM  
Adaptive Biotechnologies Receives Updated Medicare Coverage for its Minimal Residual Disease (MRD) Assay, clonoSEQ® for Blood Cancer Patients
GlobeNewswire
Nov-04-21 08:00AM  
Adaptive Reuse Apartment Conversions Hit a New Record
Motley Fool +5.17%
03:01AM  
Adaptive Biotechnologies Corporation (ADPT) Q3 2021 Earnings Call Transcript
Motley Fool
Nov-03-21 05:45PM  
Adaptive Biotechnologies (ADPT) Reports Q3 Loss, Tops Revenue Estimates
Zacks
04:05PM  
Adaptive Biotechnologies Reports Third Quarter 2021 Financial Results
GlobeNewswire
Oct-27-21 03:03PM  
Analysts Estimate Adaptive Biotechnologies (ADPT) to Report a Decline in Earnings: What to Look Out for
Zacks
Oct-18-21 05:27AM  
Hedge Funds Arent Crazy About Adaptive Biotechnologies Corporation (ADPT) Anymore
Insider Monkey
Oct-11-21 03:55PM  
Notable Adaptive Biotechnologies Insider Trades $460K In Company Stock
Benzinga
06:02AM  
What Is The Ownership Structure Like For Adaptive Biotechnologies Corporation (NASDAQ:ADPT)?
Simply Wall St.
Oct-08-21 11:57AM  
Chief Financial Officer Of Adaptive Biotechnologies Trades $395K In Company Stock
Benzinga
Oct-06-21 04:05PM  
Adaptive Biotechnologies to Report Third Quarter Financial Results on November 3, 2021
GlobeNewswire
Oct-02-21 01:15PM  
Adaptive Biotechnologies Presents New Data During IDWeek Demonstrating the Capability of Its Immune Medicine Platform to Distinguish Between SARS-CoV-2 Infection and Vaccine Response and Detect Lyme Disease
GlobeNewswire
Sep-30-21 07:30AM  
Adaptive Biotechnologies Launches Enhanced clonoSEQ® Assay Reports for Patients with Chronic Lymphocytic Leukemia, Now Featuring IGHV Mutation Status
GlobeNewswire
Sep-21-21 04:05PM  
Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footprint in Seattle
GlobeNewswire
Sep-16-21 11:24AM  
Chief Scientific Officer Of Adaptive Biotechnologies Trades $505.90 Thousand In Company Stock
Benzinga
08:03AM  
Adaptive Biotechnologies to Present New SARS-CoV-2 Data from its Immune Medicine Platform During IDWeek 2021
GlobeNewswire
Sep-13-21 11:19AM  
Adaptive Biotechnologies Insider Trades $1.67 Million In Company Stock
Benzinga
Sep-10-21 04:55PM  
Chief Financial Officer Of Adaptive Biotechnologies Trades $665.09 Thousand In Company Stock
Benzinga
Sep-07-21 05:15PM  
Adaptive Biotechnologies to Present at the Morgan Stanley Global Healthcare Conference
GlobeNewswire
Aug-15-21 06:17AM  
3 Life Science Stocks Cathy Wood's Buying Hand Over Fist Right Now
Motley Fool
Aug-12-21 01:19AM  
We're Not Very Worried About Adaptive Biotechnologies' (NASDAQ:ADPT) Cash Burn Rate
Simply Wall St.
Aug-10-21 02:11PM  
Curebase, Adaptive Biotechnologies Announce Collaboration to Expand Clinical Study Access
PR Newswire
Aug-05-21 09:01AM  
Adaptive Biotechnologies Corporation (ADPT) Q2 2021 Earnings Call Transcript
Motley Fool
Aug-04-21 06:25PM  
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates
Zacks
04:15PM  
Adaptive Biotechnologies Appoints Nitin Sood as Chief Commercial Officer
GlobeNewswire
04:05PM  
Adaptive Biotechnologies Reports Second Quarter 2021 Financial Results
GlobeNewswire
Jul-28-21 03:03PM  
Earnings Preview: Adaptive Biotechnologies (ADPT) Q2 Earnings Expected to Decline
Zacks +5.03%
Jul-19-21 09:54AM  
Exact Sciences, Vericel Corp, Home Depot, ExxonMobil and Discover Financial Services highlighted as Zacks Bull and Bear of the Day
Zacks
05:20AM  
Bull of the Day: Exact Sciences (EXAS)
Zacks
Jul-17-21 09:15AM  
Inflation Concerns Ruin First Week of Earnings Season
Zacks
Jul-12-21 04:05PM  
Adaptive Biotechnologies to Report Second Quarter Financial Results on August 4, 2021
GlobeNewswire
Jul-06-21 11:21AM  
Is Adaptive Biotechnologies Corporation (ADPT) A Good Stock To Buy?
Insider Monkey
Jun-30-21 11:17AM  
This Explosive Biotech Is Taking On a Huge New Market
Motley Fool
Jun-23-21 12:00PM  
Adaptive Biotechnologies (ADPT) Upgraded to Buy: Here's Why
Zacks
Jun-16-21 08:00AM  
Axsome (AXSM) Plans NDA Filing for Fibromyalgia Drug in 2022
Zacks
Jun-09-21 07:15AM  
New Study Published in Nature Provides Further Evidence that COVID-19 Vaccine Induced T-Cell Response Targets Known SARS-CoV-2 Variants of Concern
GlobeNewswire
Jun-03-21 07:30AM  
Adaptive Biotechnologies Included in More than 20 Abstracts at ASCO and EHA 2021 Highlighting Expanding Use Cases for MRD Testing with the clonoSEQ® Assay in Blood Cancer Patients
GlobeNewswire
May-21-21 09:55AM  
Omeros' (OMER) BLA for Narsoplimab Gets Extended Review
Zacks
May-20-21 04:05PM  
Adaptive Biotechnologies to Participate in Upcoming June 2021 Investor Conferences
GlobeNewswire
May-18-21 09:16AM  
QIAGEN (QGEN) Gains from FDA's EUA for Antibody Total Test
Zacks
08:07AM  
Bayer (BAYRY) Inks Deal to Develop Therapies for Eye Diseases
Zacks
May-17-21 12:17PM  
Dr. Reddy's (RDY) Q4 Earnings Decline Y/Y, Sales Increase
Zacks
May-11-21 11:30AM  
Perrigo (PRGO) Q1 Earnings Miss Estimates, Revenues In Line
Zacks
11:21AM  
Axsome's (AXSM) Q1 Earnings Top, AXS-05 Launch in Focus
Zacks
09:18AM  
Catalyst (CPRX) Q1 Earnings Beat Estimates, Revenues Miss
Zacks
May-06-21 03:01AM  
Adaptive Biotechnologies Corporation (ADPT) Q1 2021 Earnings Call Transcript
Motley Fool
May-05-21 07:15PM  
Adaptive Biotechnologies (ADPT) Reports Q1 Loss, Tops Revenue Estimates
Zacks
04:05PM  
Adaptive Biotechnologies Reports First Quarter 2021 Financial Results
GlobeNewswire
Apr-28-21 12:33PM  
Earnings Preview: Adaptive Biotechnologies (ADPT) Q1 Earnings Expected to Decline
Zacks
Apr-27-21 04:05PM  
Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healthcare Conference
GlobeNewswire
Apr-12-21 04:05PM  
Adaptive Biotechnologies to Report First Quarter Financial Results on May 5, 2021
GlobeNewswire
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signals; and T-Detect COVID for the confirmation of past COVID-19 infection. It also provides clonoSEQ, a clinical diagnostic product for the detection and monitoring of minimal residual disease in patients with multiple myeloma, B cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia, as well as available as a CLIA-validated laboratory developed test for patients with other lymphoid cancers; and immunoSEQ T-MAP COVID for vaccine developers and researchers to measure the T-cell immune response to vaccines. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. It serves the life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ADAMS R MARKChief Operating OfficerApr 07Sale13.1783110,944122,893Apr 08 08:00 PM
ROBINS CHAD MCEO and ChairmanMar 09Sale12.4614,815184,5951,916,154Mar 09 07:00 PM
Taylor Stacy LSVP and General CounselMar 08Sale11.442,38727,30772,859Mar 10 09:00 PM
LO FRANCISChief People OfficerMar 08Sale11.443,58240,97889,588Mar 10 04:05 PM
ROBINS CHAD MCEO and ChairmanMar 08Sale11.3814,815168,5951,916,154Mar 09 07:00 PM
BALDO LANCEChief Medical OfficerMar 08Sale11.433,35038,29017,171Mar 10 06:00 PM
ROBINS CHAD MCEO and ChairmanMar 07Option Exercise6.3214,81593,6311,930,969Mar 09 07:00 PM
ROBINS CHAD MCEO and ChairmanMar 07Sale11.5514,815171,1621,916,154Mar 09 07:00 PM
BENZENO SHARONChief Business Development OffMar 07Sale12.012,67032,067102,596Mar 08 09:01 PM
RUBINSTEIN JULIEPresidentMar 07Sale12.014,61355,402226,513Mar 08 09:01 PM
BALDO LANCEChief Medical OfficerMar 07Sale12.012,37328,50020,521Mar 08 09:01 PM
Taylor Stacy LSVP and General CounselMar 07Sale12.011,56918,84475,246Mar 08 09:00 PM
PISKEL KYLEPrincipal Accounting OfficerMar 07Sale12.012202,64247,665Mar 08 09:00 PM
LO FRANCISChief People OfficerMar 07Sale12.011,56918,84493,170Mar 08 09:00 PM
ROBINS HARLAN SChief Scientific OfficerMar 07Sale12.014,51754,249311,960Mar 08 09:00 PM
ROBINS CHAD MCEO and ChairmanMar 07Sale12.014,42453,1321,916,154Mar 08 09:00 PM
ADAMS R MARKChief Operating OfficerMar 07Sale12.011,24414,940123,724Mar 08 09:00 PM
ADAMS R MARKChief Operating OfficerJan 07Sale23.321,02123,81050,833Jan 10 08:00 PM
Taylor Stacy LSVP and General CounselDec 22Option Exercise6.9715,338106,97430,374Dec 23 09:00 PM
Cohen Chad MChief Financial OfficerDec 22Option Exercise7.2710,00072,70031,604Dec 23 09:00 PM
Taylor Stacy LSVP and General CounselDec 22Sale30.0015,338460,14015,036Dec 23 09:00 PM
Cohen Chad MChief Financial OfficerDec 22Sale30.0010,000300,00021,604Dec 23 09:00 PM
ROBINS HARLAN SChief Scientific OfficerNov 18Option Exercise6.553001,96569,660Nov 19 04:59 PM
ROBINS HARLAN SChief Scientific OfficerNov 18Sale31.363009,40869,360Nov 19 04:59 PM
ROBINS HARLAN SChief Scientific OfficerNov 17Option Exercise6.553,70024,23573,060Nov 19 04:59 PM
ROBINS HARLAN SChief Scientific OfficerNov 17Sale32.053,700118,58569,360Nov 19 04:59 PM
Cohen Chad MChief Financial OfficerNov 10Option Exercise7.275,00036,35026,604Nov 12 05:00 PM
Cohen Chad MChief Financial OfficerNov 10Sale33.935,000169,65021,604Nov 12 05:00 PM
Cohen Chad MChief Financial OfficerNov 09Option Exercise7.275,00036,35026,604Nov 12 05:00 PM
Cohen Chad MChief Financial OfficerNov 09Sale36.035,000180,15021,604Nov 12 05:00 PM
ROBINS HARLAN SChief Scientific OfficerOct 21Option Exercise6.553,70024,23573,060Oct 21 09:00 PM
ROBINS HARLAN SChief Scientific OfficerOct 21Sale33.733,700124,80169,360Oct 21 09:00 PM
ROBINS HARLAN SChief Scientific OfficerOct 20Option Exercise6.553,70024,23573,060Oct 21 09:00 PM
ROBINS HARLAN SChief Scientific OfficerOct 20Sale33.713,700124,72769,360Oct 21 09:00 PM
ROBINS HARLAN SChief Scientific OfficerOct 19Option Exercise6.553,80024,89073,160Oct 21 09:00 PM
ROBINS HARLAN SChief Scientific OfficerOct 19Sale33.693,800128,03369,360Oct 21 09:00 PM
ROBINS HARLAN SChief Scientific OfficerOct 08Option Exercise6.323,89524,61673,255Oct 08 07:00 PM
ROBINS HARLAN SChief Scientific OfficerOct 08Sale32.963,895128,37969,360Oct 08 07:00 PM
ADAMS R MARKChief Operating OfficerOct 08Sale33.671,80160,64051,854Oct 08 07:00 PM
ROBINS HARLAN SChief Scientific OfficerOct 07Option Exercise6.323,89524,61673,255Oct 08 07:00 PM
ADAMS R MARKChief Operating OfficerOct 07Sale32.471,32442,99053,655Oct 08 07:00 PM
ROBINS HARLAN SChief Scientific OfficerOct 07Sale33.623,895130,94869,360Oct 08 07:00 PM
Cohen Chad MChief Financial OfficerOct 06Option Exercise7.275,00036,35026,604Oct 07 07:00 PM
ROBINS HARLAN SChief Scientific OfficerOct 06Option Exercise6.323,89524,61673,255Oct 08 07:00 PM
ROBINS HARLAN SChief Scientific OfficerOct 06Sale32.273,895125,69269,360Oct 08 07:00 PM
Cohen Chad MChief Financial OfficerOct 06Sale32.305,000161,50021,604Oct 07 07:00 PM
Cohen Chad MChief Financial OfficerOct 05Option Exercise7.275,00036,35026,604Oct 07 07:00 PM
Cohen Chad MChief Financial OfficerOct 05Sale32.515,000162,55021,604Oct 07 07:00 PM
ROBINS HARLAN SChief Scientific OfficerSep 15Option Exercise6.323,89524,61673,255Sep 15 07:51 PM
ROBINS HARLAN SChief Scientific OfficerSep 15Sale36.683,895142,88469,360Sep 15 07:51 PM
ROBINS HARLAN SChief Scientific OfficerSep 14Option Exercise6.323,89524,61673,255Sep 15 07:51 PM
ROBINS HARLAN SChief Scientific OfficerSep 14Sale36.743,895143,08669,360Sep 15 07:51 PM
ROBINS HARLAN SChief Scientific OfficerSep 13Option Exercise6.323,89524,61673,255Sep 15 07:51 PM
ROBINS HARLAN SChief Scientific OfficerSep 13Sale37.513,895146,08469,360Sep 15 07:51 PM
ROBINS CHAD MCEO and ChairmanSep 10Sale38.385,000191,9211,673,461Sep 10 09:00 PM
ROBINS CHAD MCEO and ChairmanSep 09Sale38.4224,753951,0101,678,461Sep 10 09:00 PM
Cohen Chad MChief Financial OfficerSep 08Option Exercise7.275,00036,35026,604Sep 09 07:00 PM
ROBINS CHAD MCEO and ChairmanSep 08Sale38.4513,746528,5651,703,214Sep 10 09:00 PM
Cohen Chad MChief Financial OfficerSep 08Sale39.015,000195,05021,604Sep 09 07:00 PM
Cohen Chad MChief Financial OfficerSep 07Option Exercise6.559,37561,40630,979Sep 09 07:00 PM
Taylor Stacy LSVP and General CounselSep 07Option Exercise6.554953,24215,531Sep 09 07:00 PM
Cohen Chad MChief Financial OfficerSep 07Sale39.719,375372,28121,604Sep 09 07:00 PM
Taylor Stacy LSVP and General CounselSep 07Sale40.0049519,80015,036Sep 09 07:00 PM
ROBINS HARLAN SChief Scientific OfficerAug 27Option Exercise6.323,89524,61673,255Aug 27 09:00 PM
GRIFFIN MICHELLE RENEEDirectorAug 27Option Exercise7.8014,916116,34516,420Aug 30 08:00 PM
GRIFFIN MICHELLE RENEEDirectorAug 27Sale35.0014,916522,0601,504Aug 30 08:00 PM
ROBINS HARLAN SChief Scientific OfficerAug 27Sale34.783,895135,44969,360Aug 27 09:00 PM
ROBINS HARLAN SChief Scientific OfficerAug 26Option Exercise6.323,89524,61673,255Aug 27 09:00 PM
ROBINS HARLAN SChief Scientific OfficerAug 26Sale33.893,895132,00269,360Aug 27 09:00 PM
ROBINS HARLAN SChief Scientific OfficerAug 25Option Exercise6.323,89524,61673,255Aug 27 09:00 PM
ROBINS HARLAN SChief Scientific OfficerAug 25Sale34.093,895132,78169,360Aug 27 09:00 PM
Cohen Chad MChief Financial OfficerAug 11Option Exercise6.5510,00065,50031,604Aug 12 08:00 PM
Cohen Chad MChief Financial OfficerAug 11Sale33.6010,000336,04921,604Aug 12 08:00 PM
Cohen Chad MChief Financial OfficerAug 10Option Exercise6.555,00032,75026,604Aug 12 08:00 PM
Cohen Chad MChief Financial OfficerAug 10Sale35.005,000175,00021,604Aug 12 08:00 PM
ROBINS HARLAN SChief Scientific OfficerJul 21Option Exercise6.323,89524,61673,255Jul 21 09:00 PM
ROBINS HARLAN SChief Scientific OfficerJul 21Sale37.823,895147,29069,360Jul 21 09:00 PM
ROBINS HARLAN SChief Scientific OfficerJul 20Option Exercise6.323,89524,61673,255Jul 21 09:00 PM
ROBINS HARLAN SChief Scientific OfficerJul 20Sale37.483,895145,99669,360Jul 21 09:00 PM
Palaniappan JyotiSVP, Diagnostics, T-DetectJul 19Option Exercise22.5565114,6809,809Jul 19 09:00 PM
ROBINS HARLAN SChief Scientific OfficerJul 19Option Exercise6.323,89524,61673,255Jul 21 09:00 PM
ROBINS HARLAN SChief Scientific OfficerJul 19Sale37.123,895144,59869,360Jul 21 09:00 PM
Palaniappan JyotiSVP, Diagnostics, T-DetectJul 19Sale36.1265123,5149,158Jul 19 09:00 PM
GRIFFIN MICHELLE RENEEDirectorJul 14Option Exercise7.802,50019,5004,004Jul 19 09:00 PM
GRIFFIN MICHELLE RENEEDirectorJul 14Sale36.802,50092,0001,504Jul 19 09:00 PM
ROBINS CHAD MCEO and ChairmanJul 12Sale38.241,50157,3981,716,960Jul 14 09:00 PM
ADAMS R MARKChief Operating OfficerJul 08Sale36.302,25481,82054,979Jul 08 09:00 PM
Cohen Chad MChief Financial OfficerJul 07Option Exercise6.5510,00065,50031,604Jul 08 09:00 PM
ADAMS R MARKChief Operating OfficerJul 07Sale39.4287134,33557,233Jul 08 09:00 PM
Cohen Chad MChief Financial OfficerJul 07Sale38.5310,000385,31921,604Jul 08 09:00 PM
Cohen Chad MChief Financial OfficerJul 06Option Exercise6.5510,00065,50031,604Jul 08 09:00 PM
Cohen Chad MChief Financial OfficerJul 06Sale38.8310,000388,30021,604Jul 08 09:00 PM
Taylor Stacy LSVP and General CounselJun 30Option Exercise15.044,16762,66319,203Jul 01 09:00 PM
Taylor Stacy LSVP and General CounselJun 30Sale41.424,167172,61415,036Jul 01 09:00 PM
Palaniappan JyotiSVP, Diagnostics, T-DetectJun 18Option Exercise22.551,30129,33810,459Jun 21 08:00 PM
Palaniappan JyotiSVP, Diagnostics, T-DetectJun 18Sale39.801,30151,7809,158Jun 21 08:00 PM
GRIFFIN MICHELLE RENEEDirectorJun 17Option Exercise7.804,00031,2005,504Jun 21 08:00 PM
Palaniappan JyotiSVP, Diagnostics, T-DetectJun 17Option Exercise22.5565114,6809,809Jun 21 08:00 PM
Taylor Stacy LSVP and General CounselJun 17Option Exercise15.044,16662,65519,202Jun 21 08:00 PM
ADAMS R MARKChief Operating OfficerJun 17Option Exercise28.1014,583409,78272,687Jun 21 08:00 PM
open in yahoo | open in reuters | open in marketwatch | open in google
affiliate • advertise • contact • privacy • help
Do Not Sell My Data • Privacy Settings
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2022 FINVIZ.com. All Rights Reserved.